Chemotherapy-related peripheral neuropathy
Conditions
Interventions
Control group :Take Mecobalamin Tablets
Intervention group:Take Mecobalamin Tablets and Take Lingnan Fireneedle Therapy
Sponsors
The First Affiliated Hospital of Guangzhou TCM
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed as malignant tumor by pathology or cytology, or imaging combined with specific tumor markers; 2. Those who have received or are receiving chemotherapy combinations containing oxaliplatin and paclitaxel in the past; 3. The NCI-CTC V2.0 rating is grade I to grade III; 4. The general condition is good, the Karnofasky score is >=60, and the estimated survival period is >=5 months; 5. Age 18 to 75 years old; 6. Those without severe cardiovascular, liver, kidney, bone marrow insufficiency and normal coagulation function; 7. Sign the informed consent form and be willing to accept the treatment of this program.
Exclusion criteria
Exclusion criteria: 1. Have received other treatments similar to the measures in this study, which may affect the observers of the effect indicators of this study; 2. Nerve compression symptoms due to brain metastases or limb metastases, or neurological lesions due to electrolyte imbalance and other systemic diseases (such as severe diabetes); 3. Combining with intellectual disability or a history of mental illness and unable to conduct self-assessment; 4. Those who cannot tolerate fire acupuncture due to allergies, nervousness and other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug Toxic and Side Effects Judgment Standard V2.0;Karnofsky Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Neurophysiological testing;EORTC Quality of Life Scale; | — |
Countries
China
Contacts
Public ContactLin Shiyu
The First Affiliated Hospital of Guangzhou TCM
Outcome results
None listed